Scientific Online Resource System

Varna Medical Forum

Complementary And Alternative Medicine In The Treatment Of Cancer

Antonia Hristova, Dimana Dimitrova, Momchil Lambev, Silvia Mihaylova

Abstract

Searching for alternatives to the treatment of diseases such as cancer is where the efforts of patients and scientists are directed to. Doctors are often display a negative attitude when patients show interest in unconventional therapies and seek advice. In contrast to traditional therapies, which are usually provided only after an official scientific study of their safety and effectiveness, unconventional therapies are not scientifically justified.

About 80% of cancer patients in the United States and Canada and more than 50% of cancer patients in Europe use complementary and alternative medicine (CAM) in combination or instead of conventional therapy. The dissatisfaction with standard treatment and the side effects of chemotherapy are the most common reasons for using non-traditional methods of treatment.

Amigdaline is one of the most popular, unconventional anticancer treatments used by some 70,000 Americans in the 1970s.

Tetrahydroxycanabinol (THC) contained in cannabis oil has been shown to cause apoptosis of cancer cell lines. Cannabinoids may reduce tumor growth and progression by modulating cancer cell proliferation, tumor angiogenesis and metastasis as characteristic features of cancer.

For over 40 years Renee Kays has treated hundreds of cancer patients with Essiac. She reports that she has been using one of the herbs by injection and the others as tea and has modified the healing formula several times on the basis of her experience.

The four Essiac herbs are roots of burdock (Arctium lappa), Indian rheum (Rheum palmatum), sorrel (Rumex acetosella) and Ulmus fulva or U. rubra. Supporters of Essiac say it strengthens the immune system, improves appetite, relieves pain and improves overall quality of life. They too claim that this can reduce the size of the tumor and prolong the lives of people with various types of cancer.


Keywords

complementary and alternative medicine, cancer, Amigdalin, tetrahydroxycanabinol, Essiac

Full Text


References

Caffarel MM, Sarrio D, Palacios J, Guzman M, Sanchez C.(2006); Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Cancer Res. ;66:6615–6621.

CHARLOTTE GRAY; (CMA JOURNAL/NOVEMBER 5, 1977/VOL.117); Laetrile: Canada's legal position firm but pressure in the South grows

Chen N, Karantza-Wadsworth V. Role and regulation of autophagy in cancer.(2009), Biochim Biophys Acta 1793: 1516–1523.

Citrin DL, Bloom DL, Grutsch JF, Mortensen SJ, Lis CG (2012) Beliefs and perceptions of women with newly diagnosed breast cancer who refused conventional treatment in favor of alternative therapies. Oncologist 17: 607–612.

D. Vara, M. Salazar, N. Olea-Herrero, M. Guzma´n2, G. Velasco and I Dı´az-Laviada ,(2015), Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. This article has been corrected since Advance Online Publication and a corrigendumis also printed in this issue

Dikic I, Johansen T, Kirkin V.,(2010), Selective autophagy in cancer development and therapy. Cancer Res 2010; 70: 3431–3434.

Elizabeth Kaegi, MB, ChB, MSc, on behalf of the Task Force on Alternative Therapies of the Canadian Breast Cancer, Research Initiative,(1998), Unconventional therapies for cancer: Essiac.

ERNST T. KREBS, JR.,(1946);"CANCER OR CANCERS?"; Division of Anatomy, University of California Medical School,San Francisco 22, California.;

Ethan B. Russo,(2016); Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues

Fabricia S Predes, Ana LTG Ruiz, João E Carvalho, Mary A Foglio and Heidi Dolder, (2014); Antioxidative and in vitro antiproliferative activity of Arctium lappa root extracts.

Fischer FH, Lewith G, Witt CM, Linde K, von Ammon K, et al. (2014) High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research. BMC Complement Altern Med 14: 46.

Gillett J, Ientile C, Hiscock J, Plank A, Martin JM (2012) Complementary and alternative medicine use in radiotherapy: what are patients using? J Altern Complement Med 18: 1014–1020.

Giuliano M, Pellerito O, Portanova P, Calvaruso G, Santulli A, De Blasio A et al. ,(2009), Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma. Biochimie; 91: 457–465.

Glick D, Barth S, Macleod KF. (2010),Autophagy: cellular and molecular mechanisms. J Pathol

Huebner J, Micke O, Muecke R, Buentzel J, Prott FJ, et al. (2014) User Rate of Complementary and Alternative Medicine (CAM) of Patients Visiting a Counseling Facility for CAM of a German Comprehensive Cancer Center. Anticancer Res 34: 943–948.).

Jasmina Makarevic´, Jochen Rutz1, Eva Juengel, Silke Kaulfuss, Igor Tsaur, Karen Nelson, Jesco Pfitzenmaier, Axel Haferkamp.", Roman A. Blaheta;(2014); Amygdalin Influences Bladder Cancer Cell Adhesion and 5Invasion In Vitro

Kah Hoong Chang, Rachel Brodie, Mei Ann Choong, Karl J Sweeney, and Michael J Kerin ,(2011); Complementary and alternative medicine use in oncology: A questionnaire survey of patients and health care professionals

Liu YL, Yang PM, Shun CT, Wu MS, Weng JR, Chen CC. (2010), Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy ; 6: 1057–1065.

Lorente M, Torres S, Salazar M, Carracedo A, Hernandez-Tiedra S, Rodriguez-Fornes F, et al.(2011), Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action Cell Death Differ

Mauro Mazzocut, MS(LIS), Ivana Truccolo, MSc, Marialuisa Antonini, MSc, Fabio Rinaldi, MSc Comp Sc, PhD, Paolo Omero, MSc(Comp Sci), PhD, Emanuela Ferrarin, MSc Pharm, Paolo De Paoli, M.D, and Carlo Tasso, Eng.,(2016), Web Conversations About Complementary and Alternative Medicines and Cancer: Content and Sentiment Analysis)

Olea-Herrero N, Vara D, Malagarie-Cazenave S, Diaz-Laviada I.,(2009), Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-methanandamide and JWH-015: involvement of CB2. Br J Cancer;101:940–950.

Pellerito O, Calvaruso G, Portanova P, De Blasio A, Santulli A, Vento R et al.,(2010), The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/ CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis. Mol Pharmacol; 77: 854–863.)

Rautou PE, Mansouri A, Lebrec D, Durand F, Valla D, Moreau R.(2010), Autophagy in liver diseases. J Hepatol 2010; 53: 1123–1134).

Salazar M, Carracedo A, Salanueva IJ, Hernandez-Tiedra S, Lorente M, Egia A, et al.,(2009), Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest.;119:1359–1372

Sarfaraz S, Afaq F, Adhami VM, Mukhtar H.,(2005), Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Res. 2005;65:1635–1641

Qamri Z, Preet A, Nasser MW, Bass CE, Leone G, Barsky SH, et al.,(2009), Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Mol Cancer Ther.;8:3117–3129

Velasco G, Carracedo A, Blazquez C, Lorente M, Aguado T, Haro A, et al.,( 2007); Cannabinoids and gliomas. Mol Neurobiol.;36:60–67

Yin XM, Ding WX, Gao W. (2008), Autophagy in the liver. Hepatology ; 47: 1773–1785.




DOI: http://dx.doi.org/10.14748/vmf.v7i0.6106

Refbacks

Font Size


|